 "Top intraday picks from Geojit BNP Paribas")
SHIPPING CORPORATION OF INDIA: (Rs 89.50)
Support at Rs 87.25 below Rs 87. Resistance is at Rs 93.25 above Rs95.50. (Buy for intraday with a stoploss below Rs 87)
[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + NEW HIGH]
VENKY’S (INDIA) (Rs 477.35)
Support at Rs 472.10 below Rs 468.90. Resistance is at Rs 482.75 above Rs 494. (Buy for intraday with a stoploss below Rs 468.90)
KALINDEE RAIL NIRMAN (ENGINEERS): (Rs 141.70)
Support at Rs 138 below Rs133. Resistance is at Rs 145 above Rs 151. (Buy for intraday with a stoploss below Rs 133)
[OVERSOLD + STOCHASTICS BUY + ABV MOVING AVERAGES +VOLUME RISE]
INDRAPRASTHA MEDICAL CORPORATION (Rs 72.05)
Support at Rs 71 below Rs 68.95. Resistance is at Rs 74.25 above Rs 76 (Buy for intraday with a stoploss below Rs 68.95)
[MACD BUY+ VOLUME JUMP+ ABV MOVING AVERAGES]
NATIONAL BUILDINGS CONSTRUCTION CORPORATION: (Rs 945.35)
Support at Rs 938 below Rs 932. Resistance is at Rs 954 above Rs 968 and more. (Buy for intraday with a stoploss below Rs 932)
[MACD & STOCHASTICS BUY + VOLUME JUMP + OVERSOLD]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
Support at Rs 87.25 below Rs 87. Resistance is at Rs 93.25 above Rs95.50. (Buy for intraday with a stoploss below Rs 87)
[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + NEW HIGH]
VENKY’S (INDIA) (Rs 477.35)
Support at Rs 472.10 below Rs 468.90. Resistance is at Rs 482.75 above Rs 494. (Buy for intraday with a stoploss below Rs 468.90)
More From This Section
[VOLUME JUMP + ABV PREVIOUS CLOSE + MACD & STOCHASTICS BUY]
KALINDEE RAIL NIRMAN (ENGINEERS): (Rs 141.70)
Support at Rs 138 below Rs133. Resistance is at Rs 145 above Rs 151. (Buy for intraday with a stoploss below Rs 133)
[OVERSOLD + STOCHASTICS BUY + ABV MOVING AVERAGES +VOLUME RISE]
INDRAPRASTHA MEDICAL CORPORATION (Rs 72.05)
Support at Rs 71 below Rs 68.95. Resistance is at Rs 74.25 above Rs 76 (Buy for intraday with a stoploss below Rs 68.95)
[MACD BUY+ VOLUME JUMP+ ABV MOVING AVERAGES]
NATIONAL BUILDINGS CONSTRUCTION CORPORATION: (Rs 945.35)
Support at Rs 938 below Rs 932. Resistance is at Rs 954 above Rs 968 and more. (Buy for intraday with a stoploss below Rs 932)
[MACD & STOCHASTICS BUY + VOLUME JUMP + OVERSOLD]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.